{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:39:57Z","timestamp":1786653597370,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Stroke stands as one of the most common causes of death among adults worldwide. Currently, tissue plasminogen activator serves as the only approved drug by the Food and Drug Administration for the treatment of acute ischemic stroke. Stem cell therapy serves as a viable treatment option and has been deemed as a safe and effective treatment for stroke patients. Adult human bone marrow-derived NCS-01 cells serve as a potential treatment for stroke given their ability to reduce stroke-induced pathological deficits by increasing cell viability and mitochondrial activity. Recently, we demonstrated the use of adult bone marrow-derived NCS-01 cells both on both\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      models. Using NCS-01 cells in rat stroke models subjected to middle cerebral artery occlusion, an effective dosage of 7.5 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      cells\/ml, administered through the intracarotid artery within 3 days poststroke, was shown to display significant improvements in motor and neurological behaviors, reductions in infarct area, and peri-infarct cell loss. NCS-01 cells, in comparison with other lines of stem cells (Li cells), are shown to produce greater therapeutic effects, most likely due to the observed filopodia formation that allows the stem cells to extend and target the ischemic cells. Given these findings, NCS-01 stem cells serve as a potential treatment for stroke through the demonstration of profound efficacy and further research that favors their filopodia-mediated mechanism of action.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/bc.bc_23_21","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T08:21:48Z","timestamp":1617092508000},"page":"44-47","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Bone marrow-derived NCS-01 cells for ischemic stroke"],"prefix":"10.4103","volume":"7","author":[{"given":"Madeline","family":"Saft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesario V.","family":"Borlongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20240830","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/sctm.19-0229","article-title":"Translating intracarotid artery transplantation of bone marrow-derived NCS-01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into stem cell therapy","volume":"9","author":"Kaneko","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"R2-11-20240830","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: A report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"R3-11-20240830","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: Heart disease and stroke statistics-2014 update: A report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"R4-11-20240830","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5853\/jos.2019.00584","article-title":"tPA helpers in the treatment of acute ischemic stroke: Are they ready for clinical use?","volume":"21","author":"Kim","year":"2019","journal-title":"J Stroke"},{"key":"R5-11-20240830","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2184.2008.00486.x","article-title":"Stem cells and neurological diseases","volume":"41","author":"Hess","year":"2008","journal-title":"Cell Prolif"},{"key":"R6-11-20240830","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jnr.23879","article-title":"Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease","volume":"95","author":"Chen","year":"2017","journal-title":"J Neurosci Res"},{"key":"R7-11-20240830","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/14653240802021330","article-title":"Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease","volume":"10","author":"Levy","year":"2008","journal-title":"Cytotherapy"},{"key":"R8-11-20240830","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/scd.2008.0411","article-title":"Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease","volume":"18","author":"Sadan","year":"2009","journal-title":"Stem Cells Dev"},{"key":"R9-11-20240830","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jcyt.2014.02.003","article-title":"Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis","volume":"16","author":"Boido","year":"2014","journal-title":"Cytotherapy"},{"key":"R10-11-20240830","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/stem.1812","article-title":"Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS","volume":"32","author":"Forostyak","year":"2014","journal-title":"Stem Cells"},{"key":"R11-11-20240830","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuroscience.2013.05.034","article-title":"Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model","volume":"248","author":"Marconi","year":"2013","journal-title":"Neuroscience"},{"key":"R12-11-20240830","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2174\/15672050113109990027","article-title":"Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-\u03b2 deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease","volume":"10","author":"Bae","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"R13-11-20240830","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neurobiolaging.2010.03.024","article-title":"Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation","volume":"33","author":"Lee","year":"2012","journal-title":"Neurobiol Aging"},{"key":"R14-11-20240830","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/STROKEAHA.115.009854","article-title":"Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke","volume":"46","author":"Acosta","year":"2015","journal-title":"Stroke"},{"key":"R15-11-20240830","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/sctm.19-0076","article-title":"Concise review: Stem cell therapy for stroke patients: Are we there yet?","volume":"8","author":"Borlongan","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"R16-11-20240830","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/jcbfm.2013.91","article-title":"Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke","volume":"33","author":"Eckert","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"R17-11-20240830","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.STR.0000247888.25985.62","article-title":"Cell transplantation therapy for stroke","volume":"38","author":"Bliss","year":"2007","journal-title":"Stroke"},{"key":"R18-11-20240830","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1440-1789.2002.00450.x","article-title":"Ischemic rat brain extracts induce human marrow stromal cell growth factor production","volume":"22","author":"Chen","year":"2002","journal-title":"Neuropathology"},{"key":"R19-11-20240830","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pneurobio.2013.11.007","article-title":"Cell based therapies for ischemic stroke: From basic science to bedside","volume":"115","author":"Liu","year":"2014","journal-title":"Prog Neurobiol"},{"key":"R20-11-20240830","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/bc.bc_36_19","article-title":"Altered metabolism for neuroprotection provided by mesenchymal stem cells","volume":"5","author":"Lyden","year":"2019","journal-title":"Brain Circ"},{"key":"R21-11-20240830","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann Neurol"},{"key":"R22-11-20240830","doi-asserted-by":"crossref","first-page":"e57430","DOI":"10.1371\/journal.pone.0057430","article-title":"Overexpression of CD44 in neural precursor cells improves trans-endothelial migration and facilitates their invasion of perivascular tissues in vivo","volume":"8","author":"Deboux","year":"2013","journal-title":"PLoS One"},{"key":"R23-11-20240830","doi-asserted-by":"crossref","first-page":"21926","DOI":"10.1074\/jbc.M113.532358","article-title":"Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics","volume":"289","author":"Ahn","year":"2014","journal-title":"J Biol Chem"},{"key":"R24-11-20240830","doi-asserted-by":"crossref","first-page":"17470","DOI":"10.1038\/srep17470","article-title":"Fine-tuned SRF activity controls asymmetrical neuronal outgrowth: Implications for cortical migration, neural tissue lamination and circuit assembly","volume":"5","author":"Scandaglia","year":"2015","journal-title":"Sci Rep"},{"key":"R25-11-20240830","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/bc.bc_14_18","article-title":"Mitochondrial targeting as a novel therapy for stroke","volume":"4","author":"Russo","year":"2018","journal-title":"Brain Circ"}],"container-title":["Brain Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_23_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:50Z","timestamp":1786649990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_23_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/bc.bc_23_21","relation":{},"ISSN":["2394-8108"],"issn-type":[{"value":"2394-8108","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}